Category Archives : Oncologist

Oncotarget Makes a Point to Stay on Point

Oncotarget is a community of writers, information hunters and fact checkers that focus on archiving and distributing specialized and formatted content. They work on the subjects of oncology, pharmacology, neuroscience, endocrinology, cell biology, metabolism, cardiology and other fields of medical science. The website they manage is simple but powerful. It has all the features and credentials that an audience needs to trust in their source of information without anything extra to distract from its purpose. With a founding date that originates in 2013, the site can be considered very green by some standards. And, that just might be a blessing in disguise. This “under the radar” feel to the organization means it is still untrammeled by the SEO wars in which so many pages and organizations find themselves caught in the crossfire. Learn more about Oncotarget at

Oncotarget has the feel of an online organization with academic book smarts and countless laboratory time logged mixed with the everyday working professionals philosophy. The fact that they are inclusive in their modus operandi, points to a sincere and ground breaking desire, to see a change in the modern medical treatment of diseases. On the same note, having the hierarchy of the establishment easily accessible says that the integrity of what they do remains intact. Not to mention the consistent weekly release of findings and submissions reveals a collective dedication that most people are only aware of as clients or patrons in their daily lives. But, does the average person really does not have a full understanding of the effort required to pull such a thing off? An answer of “yes” from most citizens would be highly dubious. For that fact alone, these professional are to be commended.

Here is the meat and potatoes about the work Oncotarget does. If you are a person with a private or personal reason for knowing more about oncology, pharmacology, neuroscience, endocrinology, cell biology, metabolism, cardiology and other diseases, this community website is for you. If you are someone who unabashedly says “I heart biology”, then this sight should serve you well. Of course, anyone seeking a resource for quality studies to review and share should get involved. It kind of goes without saying, but this group of like-minded individuals is serious about their work product, and anyone looking to get started with them should be equally committed to the project.

Read more

The Successful Career Of Mikhail Blagosklonny

Mikhail Blagosklonny is cancer and aging researcher at the Roswell Park Cancer Institute. The scientist is also a professor of oncology at the Institute. He resides in New York.
Blagosklonny has a sound educational background. He studied M.D in internal medicine at the First Pavlov State Medical University of St. Petersburg. His desire to learn more in the field saw him enroll for a doctorate in experimental medicine and cardiology at the same university.

After completing his doctorate degree, he was appointed by the New York Medical College as an associate professor of medicine. He served at the college for some time. In 2002, he moved to Ordway Research Institute. At Ordway, he worked as a senior scientist. In this facility, which is located in Albany, New York, he was charged with researching on aging and cancer on After seven years working at the Institute, he went to serve as an oncology professor at Roswell Park Cancer Institute. He has worked at this institution since then.

The Roswell Park Cancer Institute believes that Mikhail Blagosklonny will ignite the research works already going at the institute and provide a new point of view. At Roswell, Blagosklonny has played a pivotal role in furthering human’s knowledge on cancer. He primarily researches on cancer, targeted cancer therapies, how to protect healthy cells, and the underlying mechanisms of aging. He also studies how cancer drugs can be used to treat aging.

Recently, the scientist formulated a hypothesis on TOR signaling and aging. His hypothesis claimed that TOR signaling plays a critical role in aging and cancer. If it is true, it means that cancer drugs such as rapamycin could be used as a possible treatment for life extension. He is one of the main supporters of the drug. Mikhail has called for other scientists to research further into the idea on

The scientist is an editor. He is associated with Cell Cycle, Aging, and Oncotarget. He is the editor-in-chief of these journals. Blagosklonny is also Cancer Biology & Therapy’s associate editor. Moreover, he is actively involved in the editorial board of Cell Death & Differentiation.

Mikhail Blagosklonny is also the author of over 270 articles. His papers have been published in many peer-reviewed journals. In addition, he has over 25,000 citations. This high number of citations has earned him an h-index of 83. Some of his publications include “Oncogenic Resistance to Growth-Limiting Conditions’ and ‘Conceptual Biology: Unearthing the Gems.’ Mikhail’s works have been published in authoritative journals such as Nature Review Cancer, Nature Leukemia, and Autophagy.

Back to Top